Short-term outcomes of rituximab versus thrombopoietin receptor agonists in Myelodysplastic Syndromes: A 90-day propensity-matched analysis using real-world data
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Jamil Nazzal, Mohammad Salameh, Zaid Zahid, Jasneet Randhawa, Mostafa Abdalla, Ahmad Alkhatib, Kinan Obeidat, Lisa Duhaime
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417007308
Cites:
Cited by:
Related to: